SHELTON JERRELL 4

What Happened

• Shelton Jerrell, President, CEO and director of Cryoport (CYRX), was granted 492,901 derivative shares (award) on 2026-03-14 (acquired at $0.00) and sold 7,918 common shares in an open‑market or private sale on 2026-03-16 at $8.00 each for proceeds of $63,344. The filing shows the sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock rights.

Key Details

• Transactions:
  • 2026-03-14 — Award/Grant (code A): 492,901 shares @ $0.00 (derivative grant).
  • 2026-03-16 — Sale (code S): 7,918 shares @ $8.00 = $63,344 (disposed).
• Footnotes:
  • F1: Shares sold to pay taxes due on the vesting of restricted stock rights (tax withholding).
  • F2: Relates to options that vest 1/48 on the 14th of each month beginning April 14, 2026 (monthly vesting schedule).
• Shares owned after the reported transactions were not included in the provided data.
• Filing date: 2026-03-17. With transactions on 3/14 and 3/16, the Form 4 appears to have been filed within the normal SEC reporting window (timely).

Context

• The 492,901 shares reported at $0.00 are an award/derivative grant (e.g., restricted stock/RSU type award) rather than an open‑market purchase; the subsequent small sale was used for tax withholding and is commonly routine. Awards and withholding sales do not, by themselves, indicate a buy/sell sentiment; purchases of stock are generally viewed as a stronger sign of insider bullishness. The F2 note indicates an option grant with a standard 48‑month monthly vesting schedule starting April 14, 2026.